SE448876B - Inre salter av sulfoxi-triazinium-, -pyrimidinium- och -pyridiniumhydroxid och sett att framstella dessa - Google Patents

Inre salter av sulfoxi-triazinium-, -pyrimidinium- och -pyridiniumhydroxid och sett att framstella dessa

Info

Publication number
SE448876B
SE448876B SE8101421A SE8101421A SE448876B SE 448876 B SE448876 B SE 448876B SE 8101421 A SE8101421 A SE 8101421A SE 8101421 A SE8101421 A SE 8101421A SE 448876 B SE448876 B SE 448876B
Authority
SE
Sweden
Prior art keywords
sulfoxy
inner salt
hydroxide
diamino
amino
Prior art date
Application number
SE8101421A
Other languages
English (en)
Swedish (sv)
Other versions
SE8101421L (sv
Inventor
J M Mccall
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of SE8101421L publication Critical patent/SE8101421L/xx
Publication of SE448876B publication Critical patent/SE448876B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50Three nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40Nitrogen atoms
    • C07D251/54Three nitrogen atoms
    • C07D251/70Other substituted melamines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
SE8101421A 1980-03-10 1981-03-05 Inre salter av sulfoxi-triazinium-, -pyrimidinium- och -pyridiniumhydroxid och sett att framstella dessa SE448876B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/128,995 US4287338A (en) 1980-03-10 1980-03-10 Sulfooxy-pyrimidinium, -pyridinium, and -triazinium hydroxide inner salts

Publications (2)

Publication Number Publication Date
SE8101421L SE8101421L (sv) 1981-09-11
SE448876B true SE448876B (sv) 1987-03-23

Family

ID=22437996

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8101421A SE448876B (sv) 1980-03-10 1981-03-05 Inre salter av sulfoxi-triazinium-, -pyrimidinium- och -pyridiniumhydroxid och sett att framstella dessa

Country Status (15)

Country Link
US (1) US4287338A (it)
JP (1) JPS56150066A (it)
AU (1) AU536166B2 (it)
BE (1) BE887850A (it)
CA (1) CA1154761A (it)
CH (1) CH645626A5 (it)
DE (1) DE3107583A1 (it)
FI (1) FI70410C (it)
FR (1) FR2477541A1 (it)
GB (1) GB2071092B (it)
HK (1) HK98088A (it)
IT (1) IT1142667B (it)
NL (1) NL8101114A (it)
SE (1) SE448876B (it)
ZA (1) ZA811057B (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514672A (en) * 1981-02-17 1996-05-07 Bazzano; Gail S. Use of retinoids and compositions containing same for hair growth
US5183817A (en) * 1981-02-17 1993-02-02 Bazzano Gail S Combinations of retinoids and minoxidil-type compounds for hair growth
US4532240A (en) * 1982-09-09 1985-07-30 Warner-Lambert Company Diaminopyrimidines
DE3670765D1 (en) * 1985-01-25 1990-06-07 Upjohn Co Pyrimidinsulfate fuer haarwuchs.
FR2590897B1 (fr) * 1985-12-06 1988-02-19 Kemyos Bio Medical Research Sr Nouveaux derives de 6 amino 1,2-dihydro-1-hydroxy-2-imino-pyrimidine, leur procede de preparation et compositions cosmetiques les renfermant
US4927626A (en) * 1988-10-28 1990-05-22 Devillez Richard L Method for enhancement of unguis growth
FR2651122B1 (fr) * 1989-08-29 1994-10-28 Oreal Compositions destinees a etre utilisees pour freiner la chute des cheveux et pour induire et stimuler leur croissance, contenant des derives de l'amino-2 pyrimidine oxyde-3 et nouveaux composes derives de l'amino-2 pyrimidine oxyde-3.
GB8929022D0 (en) * 1989-12-22 1990-02-28 Ici Plc Diazine derivatives
GB9008818D0 (en) * 1990-04-19 1990-06-13 Ici Plc Amine derivatives
DE69108402T2 (de) * 1990-11-14 1995-10-05 Upjohn Co 5-fluor-2,4,6-pyrimidinthiaminderivate zur verhinderung des haarsausfalls.
FR2671082B1 (fr) * 1990-12-28 1993-04-16 Oreal Agent a plusieurs composants ou kit de preparation de la forme sulfo-conjuguee de composes pyrimidino- ou triazino-n-oxyde et procede de mise en óoeuvre.
FR2677884B1 (fr) * 1991-06-20 1993-07-09 Oreal Composition pour freiner la chute des cheveux a base de pyrimidines n-oxyde trisubstitues ou leurs derives sulfoconjugues, nouveaux composes pyrimidines n-oxyde ou leurs derives sulfoconjugues.
CN1280274C (zh) 1997-08-01 2006-10-18 莱利工业公司 4-(仲或叔)氨基吡啶催化剂
WO2006091587A2 (en) * 2005-02-22 2006-08-31 Cedars-Sinai Medical Center Use of minoxidil sulfate as an anti-tumor drug
TW200904437A (en) * 2007-02-14 2009-02-01 Janssen Pharmaceutica Nv 2-aminopyrimidine modulators of the histamine H4 receptor
EP2144877A1 (en) * 2007-04-04 2010-01-20 UCB Pharma, S.A. Novel pyridine derivatives, processes for preparing them, pharmaceutical compositions thereof
US8470833B2 (en) 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Hair growth and/or regrowth compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3270014A (en) * 1965-07-01 1966-08-30 Upjohn Co 1, 2-dihydro-1-hydroxy-1, 3, 5-triazines
US3461461A (en) * 1965-11-01 1969-08-12 Upjohn Co 6-amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidines
US3464987A (en) * 1966-02-21 1969-09-02 Upjohn Co 1,2-dihydro-1-hydroxy-2-imino-6-(lower alkyl)pyrimidines
US3973016A (en) * 1974-08-05 1976-08-03 Warner-Lambert Company Blood pressure reducing hydroxypyrimidines
US4021562A (en) * 1975-12-08 1977-05-03 Mead Johnson & Company 4-Tertiary-amino-2,6-diaminopyridine 1-oxides

Also Published As

Publication number Publication date
CH645626A5 (de) 1984-10-15
FR2477541A1 (fr) 1981-09-11
JPH0145467B2 (it) 1989-10-03
FI810681L (fi) 1981-09-11
BE887850A (fr) 1981-09-09
FI70410C (fi) 1986-09-19
AU536166B2 (en) 1984-04-19
CA1154761A (en) 1983-10-04
IT1142667B (it) 1986-10-15
HK98088A (en) 1988-12-09
GB2071092A (en) 1981-09-16
NL8101114A (nl) 1981-10-01
AU6737181A (en) 1981-09-17
FI70410B (fi) 1986-03-27
DE3107583A1 (de) 1982-01-07
ZA811057B (en) 1982-03-31
DE3107583C2 (it) 1989-11-02
IT8147976A0 (it) 1981-03-09
US4287338A (en) 1981-09-01
GB2071092B (en) 1983-09-07
JPS56150066A (en) 1981-11-20
SE8101421L (sv) 1981-09-11
FR2477541B1 (it) 1984-06-01

Similar Documents

Publication Publication Date Title
SE448876B (sv) Inre salter av sulfoxi-triazinium-, -pyrimidinium- och -pyridiniumhydroxid och sett att framstella dessa
US4483859A (en) 4-Amino-6, 7-dimethoxy-2-(4-heteroaryl-piperazino) quinazoline _antihypertensives
CA3200245A1 (en) Benzimidazole derivative and preparation method therefor and medical use thereof
EP0877744B1 (de) Substituierte aza- und diazacycloheptan- und -cyclooctanverbindungen und deren verwendung
EP1601659B1 (de) Pyrimidin-2-on-verbindungen und ihre verwendung als dopamin-d3-rezeptorliganden
EP3225619A1 (en) 2-aminopyrimidine compound and pharmaceutical composition and use thereof
US4746664A (en) Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent
JP2014522860A (ja) Btk阻害剤としての4−イミダゾピリダジン−1−イル−ベンズアミドおよび4−イミダゾトリアジン−1−イル−ベンズアミド
PL202675B1 (pl) Zastosowanie hamującej HIV, pochodnej pirymidyny, pochodna pirymidyny i sposób jej wytwarzania oraz kompozycja farmaceutyczna
EP0084250B1 (en) 6-(substituted phenyl)-4,5-dihydro-3-(2h)-pyridazinone compounds and processes for their preparation
EP0163599A2 (en) Pyrimidopyrimidine derivatives, processes for producing them, pharmaceutical compositions containing them and their use as anti-allergic agents
DD150609A5 (de) Verfahren zur herstellung von pyrimidin-verbindungen
WO2003099231A2 (en) Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins
AU2019233209A1 (en) Crystal form of monomethanesulfonate of deuterated 3-(4,5-substituted aminopyrimidine)phenyl compound, and preparation method therefor
CZ307994A3 (en) Novel biologically active derivatives of eburnamenin, pharmaceutical compositions containing thereof and process of their preparation
GB2083474A (en) N-(4-3-substituted pyridyl piperazino) alkyl azaspirodecanediones
AU2005311452A1 (en) Triazole compounds suitable for treating disorders that respond to modulaiont of the dopamine D3 receptor
FI88300C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara diazinylpiperidinderivat av cykliska amider och imider
JPH0528701B2 (it)
EP0796251B1 (de) Uracilderivate
JPS61204186A (ja) ピリダジノピロロイソキノリン誘導体
US6403593B1 (en) Triazole compounds and the use thereof
JPS62270563A (ja) ピリミジン誘導体
KR820001387B1 (ko) 옥사디아졸로 피리미딘 유도체의 제조방법
CA1136131A (en) Pyrimidine compounds, processes for their preparation, pharmaceutical preparations containing these compounds, and their use in therapeutics

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8101421-9

Effective date: 19941010

Format of ref document f/p: F